Intervention not reported
5‐year disease specific survival rate (5 to 15 yr) · women with locally advanced uterine cervix cancer
The intervention showed no clear difference in 5‐year disease specific survival rate (5 to 15 yr) (moderate certainty).
1 finding from 1 review
Intervention not reported
10‐year disease specific survival rate (5 to 15 yr) · women with locally advanced uterine cervix cancer
The intervention showed no clear difference in 10‐year disease specific survival rate (5 to 15 yr) (moderate certainty).
1 finding from 1 review
Intervention not reported
3‐year relapse‐free survive rate (37.2/40.2 mo) · women with locally advanced uterine cervix cancer
The intervention showed no clear difference in 3‐year relapse‐free survive rate (37.2/40.2 mo) (low certainty).
1 finding from 1 review
Intervention not reported
5‐year relapse‐free survive rate (66 mo) · women with locally advanced uterine cervix cancer
The intervention showed no clear difference in 5‐year relapse‐free survive rate (66 mo) (low certainty).
1 finding from 1 review
Intervention not reported
3‐year local control rate (37.2/40.2 mo) · women with locally advanced uterine cervix cancer
The intervention showed no clear difference in 3‐year local control rate (37.2/40.2 mo) (low certainty).
1 finding from 1 review
Intervention not reported
5‐year local control rate (3 to 6 yr) · women with locally advanced uterine cervix cancer
The intervention showed no clear difference in 5‐year local control rate (3 to 6 yr) (low certainty).
1 finding from 1 review
Intervention not reported
Child cognitive ability As assessed by the Griffith Mental Development scale at 18‐month · children younger than five years of age and their families
It is very uncertain whether the intervention changes child cognitive ability As assessed by the Griffith Mental… (very low certainty).
1 finding from 1 review
Intervention not reported
Child psychosocial development Parents reporting their child develops abnormally · children younger than five years of age and their families
It is very uncertain whether the intervention changes child psychosocial development Parents reporting their child… (very low certainty).
1 finding from 1 review
Intervention not reported
Paid maternal employment Mothers in full‐time or part‐time employment · children younger than five years of age and their families
It is very uncertain whether the intervention changes paid maternal employment Mothers in full‐time or part‐time employment (very low certainty).
1 finding from 1 review
Intervention not reported
Paid maternal employment Maternal hours per week in paid employment · children younger than five years of age and their families
It is very uncertain whether the intervention changes paid maternal employment Maternal hours per week in paid employment (very low certainty).
1 finding from 1 review
Intervention not reported
Household income Households with weekly income > £200 · children younger than five years of age and their families
It is very uncertain whether the intervention changes household income Households with weekly income > £200 (very low certainty).
1 finding from 1 review
Intervention not reported
Mortality (after 3 years) · Patients with refractory/relapsed Hodgkin lymphoma
The intervention showed no clear difference in mortality (after 3 years) (moderate certainty).
1 finding from 1 review
Intervention not reported
Relapse or death (at 3 years) · Patients with refractory/relapsed Hodgkin lymphoma
The intervention probably leads to lower relapse or death (at 3 years) (moderate certainty).
1 finding from 1 review
Intervention not reported
Treatment‐related mortality ‐ overall analysis (at 3 years) · Patients with refractory/relapsed Hodgkin lymphoma
The intervention showed no clear difference in treatment‐related mortality ‐ overall analysis (at 3 years) (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events not estimable · Patients with refractory/relapsed Hodgkin lymphoma
1 finding from 1 review
Intervention not reported
Quality of life not reported · Patients with refractory/relapsed Hodgkin lymphoma
1 finding from 1 review
Intervention not reported
Overall survival · Adult patients with follicular lymphoma
The intervention showed no clear difference in overall survival (moderate certainty).
1 finding from 1 review
Intervention not reported
Treatment‐related mortality · Adult patients with follicular lymphoma
The intervention showed no clear difference in treatment‐related mortality (moderate certainty).
1 finding from 1 review
Intervention not reported
Progression‐free survival · Adult patients with follicular lymphoma
The intervention probably leads to lower progression‐free survival (moderate certainty).
1 finding from 1 review
Intervention not reported
Secondary malignancies AML/MDS · Adult patients with follicular lymphoma
The intervention showed no clear difference in secondary malignancies AML/MDS (low certainty).
1 finding from 1 review